InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Freeman Mason, Directeur Exécutif du Développement Clinique. Insider active across 1 company, notably CinCor Pharma, Inc.. Aggregated, 2 disclosures have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €71k. History available since 11 January 2022. The latest transaction was disclosed on 11 January 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations2 total
2,500 shares@ US$16.00100.0% of flowCommon StockSEC:0001209191-22-003188
Canonical exit: 11 Apr 2022 (T+90)
2,500 shares@ US$16.0050.0% of flowCommon StockSEC:0001209191-22-003188:0
Canonical exit: 11 Apr 2022 (T+90)
2 of 2 declarations
About Freeman Mason
Mason Freeman is the EVP Clinical Development at CinCor Pharma, Inc. In this role, he oversees clinical development programs and ensures that clinical trials are conducted in compliance with regulatory standards. His expertise is essential for the success of the company's research initiatives.
